Insider Trading activities at Neon Therapeutics, Inc. (NTGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neon Therapeutics, Inc. (NTGN) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neon Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1694187.

Total stock buying since 2018: $5,040,000.
Total stock sales since 2018: $847,593.
Total stock option exercises since 2018: $149,997.


4 insiders reported insider trading activities at Neon Therapeutics, Inc. (NTGN):
Insider trading activities of O'dowd Hugh
Insider trading activities of Al-wakeel Yasir B.
Insider trading activities of Gaynor Richard
Insider trading activities of Blavatnik Len

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Neon Therapeutics, Inc. (NTGN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2020 0 $0 345,433 $762,237 0 $0
2019 0 $0 65,322 $85,356 0 $0
2018 315,000 $5,040,000 0 $0 36,109 $149,997

Table 2. Monthly summary of insider trading at Neon Therapeutics, Inc. (NTGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-03 0 $0 345,433 $762,237 0 $0
2019-11 0 $0 65,322 $85,356 0 $0
2018-08 0 $0 0 $0 18,868 $50,000
2018-07 0 $0 0 $0 17,241 $99,997
2018-06 315,000 $5,040,000 0 $0 0 $0

Table 3. Detailed insider trading at Neon Therapeutics, Inc. (NTGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-03-24 Blavatnik Len (Other) Sale 201,686 2.20 443,104
2020-03-23 Blavatnik Len (Other) Sale 50,358 2.17 109,478
2020-03-20 Blavatnik Len (Other) Sale 84,339 2.22 186,895
2020-03-19 Blavatnik Len (Other) Sale 9,050 2.52 22,760
2019-11-27 Gaynor Richard (President of R&D) Sale 22,322 1.24 27,634
2019-11-26 Gaynor Richard (President of R&D) Sale 23,000 1.31 30,222
2019-11-25 Gaynor Richard (President of R&D) Sale 20,000 1.38 27,500
2018-08-20 O'dowd Hugh (President & CEO) Option Ex 18,868 2.65 50,000
2018-07-17 Al-wakeel Yasir B. (Chief Financial Officer) Option Ex 17,241 5.80 99,997
2018-06-29 Blavatnik Len (Other) Buy 315,000 16.00 5,040,000

Insider trading activities including stock purchases, stock sales, and option exercises of NTGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neon Therapeutics, Inc. (symbol NTGN, CIK number 1694187) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.